Wearable device tracks individual cells in the bloodstream in real time
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
MIT engineers developed ultrathin electronic films that sense heat and other signals, and could reduce the bulk of conventional goggles and scopes.
Professor Craig Carter’s precision design for a student-led project now on the moon encodes messages from around the world on a silicon wafer.
Inaugural cohort of Tecnológico de Monterrey undergraduates participate in immersive practicum at MIT featuring desktop fiber-extrusion devices, or FrEDs.
Scaling up nanoparticle production could help scientists test new cancer treatments.
Metallurgist brings experience in interdisciplinary collaboration and close engagement with industry.
Mechanical metamaterials research demands interdisciplinary collaboration and innovation, say researchers from MechE's Portela Lab.
In MIT’s 2025 Killian Lecture, physicist John Joannopoulos recounts highlights from a career at the vanguard of photonics research and innovation.
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Rhombohedral graphene reveals new exotic interacting electron states.
When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.
With technology developed at MIT, 6K is helping to bring critical materials production back to the U.S. without toxic byproducts.
The nanoparticle-based vaccine shows promise against many variants of SARS-CoV-2, as well as related sarbecoviruses that could jump to humans.
With seven new startups, MIT.nano's program for hard-tech ventures expands to more than 20 companies.